Table 5

 Sleep stages, mean and nadir oxygen saturation at baseline, after a single withdrawal night of NMV at 6 months (T6) and 12 months (T12–), and with NMV (T12+)

MeasurementsANOVAT12+
BaselineT6−T12−
Mean Sao 2-NREM (%)74.3  (9.7)83.6  (6.2)89.1  (4.1)0.000192.7  (2.11)
Mean Sao 2-REM (%)63.8 (9.8)72.6 (6.2)77.9 (4.1)0.000181.1 (2.2)
Nadir Sao 2-NREM (%)61.7 (11.6)70.6 (8.8)80.3 (5.8)0.000187.0 (2.9)
Nadir Sao 2-REM (%)50.1 (9.5)61.0 (8.3)70.3 (6.4)0.000179.5 (5.1)
Awakenings (1/h)29.4 (20.1)19.4 (15.5)12.4 (11.6)0.00056.1 (6.0)
TST (min)219.3 (52.0)275.3 (60.0)276.6 (43.3)0.0001283.5 (40.8)
SL (min)29.0 (17.5)30.1 (18.7)35.6 (23.1)0.3026.1 (13.5)
SE (%)64.1 (11.0)73.4 (10.8)73.5 (8.5)0.00281.3 (7.9)
REM (% TST)5.2 (4.2)8.5 (6.3)10.4 (5.0)0.00414.6 (6.0)
REM-L (min)94.9 (33.7)71.1 (36.4)75.9 (25.7)0.2271.3 (35.4)
NREM 1 & 2 (% TST)86.2 (13.0)81.0 (12.0)74.0 (8.8)0.000267.1 (8.3)
NREM 3 & 4 (% TST)8.4 (10.5)10.6 (7.9)16.0 (7.7)0.00418.6 (7.7)
  • Values are mean (SD).

  • Analysis of variance (ANOVA) for repeated measures was used as a global test (p <0.05 was considered significant).

  • NREM = non-rapid eye movement sleep; REM = rapid eye movement sleep; REM-L = rapid eye movement sleep latency; Sao 2= oxygen saturation; SL = sleep latency; SE = sleep efficacy; TST = total sleep time.